(Q36857391)

16 August 2017

Peripheral endocannabinoid system activity in patients treated with sibutramine (English)

1 reference

16 August 2017

endocannabinoid system

0 references

author

Pal Pacher

6

1 reference

16 August 2017

Karsten Heusser

2

0 references

Friedrich C. Luft

object named as

Friedrich C Luft

8

0 references

Judy Harvey-White

7

object named as

Judith Harvey-White

1 reference

16 August 2017

1

Stefan Engeli

1 reference

16 August 2017

9

Jens Jordan

1 reference

16 August 2017

Jürgen Janke

3

1 reference

16 August 2017

Kerstin Gorzelniak

4

1 reference

16 August 2017

Sándor Bátkai

5

1 reference

16 August 2017

6 March 2008

1 reference

16 August 2017

1 reference

16 August 2017

16

1 reference

16 August 2017

5

1 reference

16 August 2017

1135-1137

1 reference

Serotonin and norepinephrine reuptake inhibition and eating behavior

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

The endocannabinoid system as an emerging target of pharmacotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Activation of the peripheral endocannabinoid system in human obesity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

A review of the metabolic effects of sibutramine.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Leptin-regulated endocannabinoids are involved in maintaining food intake

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527586

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FOBY.2008.47

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

31 March 2020

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FOBY.2008.47

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.47

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18356837

1 reference